Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck Opens Asia Pacific Headquarters In Singapore

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm’s total investment in the country is more than $650 million.

You may also be interested in...

Asia Set To Become New Center Of Pharma: PricewaterhouseCoopers Report

China and India seen as countries with the highest growth potential.

Genentech Boosts Singapore Presence With $140 Million Biologics Plant

Lilly also increases R&D efforts in nation with a $150 million expansion.

Singapore Biomedical Sciences Group Director Yeoh Keat Chuan: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)

Singapore government official talks about the country’s R&D strengths and how it is handling increased competition from other Asian nations.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts